NOVONESIS (NOVOZYMES) B (NZM2.DE) Stock Cash Flow
Europe - Frankfurt Stock Exchange - FRA:NZM2 - DK0060336014 - Common Stock
53.54 EUR
+0.34 (+0.64%)
| TTM (2025-9-30) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | 702.70M | 305.80M | 3.04B | 3.69B | 3.15B | |||
| Depreciation Amortization | N/A | 597.40M | 186.03M | 198.89M | 189.89M | |||
| Change In Working Capital | -340.90M | -80.10M | -139.56M | -216.30M | -171.79M | |||
| Interest Paid | 95.90M | 76.00M | 21.03M | 17.55M | 6.97M | |||
| Taxes Paid | 263.90M | 300.20M | 105.81M | 121.88M | 84.08M | |||
| Other non cash items | 1.02B | 196.80M | 102.59M | 60.27M | 104.87M | |||
| OPERATING CASH FLOW | 1.39B | 1.02B | 556.09M | 536.54M | 544.74M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -456.20M | -359.80M | -275.37M | -387.07M | -166.29M | |||
| Other Investing Activity | -1.43B | 160.10M | -10.31M | 29.20M | -202.10M | |||
| INVESTING CASH FLOW | -1.89B | -199.70M | -285.68M | -357.87M | -368.39M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 1.10B | -405.30M | 107.15M | 81.83M | 143.63M | |||
| Stock Issued/Repurchased | -42.50M | 37.80M | 22.37M | -45.00M | -159.72M | |||
| Dividend Paid | N/A | -249.70M | -378.36M | -204.12M | -196.46M | |||
| Other Financing Activity | N/A | -86.00M | -4.15M | -133.90K | -134.10K | |||
| FINANCING CASH FLOW | 525.60M | -703.20M | -253.00M | -167.42M | -212.69M | |||
| Exchange Rate Effect | -700.00K | 13.30M | -7.37M | -803.60K | 7.11M | |||
| CHANGE IN CASH | 20.50M | 130.30M | 10.04M | 10.45M | -29.23M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | 1.39B | 1.02B | 556.09M | 536.54M | 544.74M | |||
| Capital Expenditure | -456.20M | -359.80M | -275.37M | -387.07M | -166.29M | |||
| FREE CASH FLOW | 928.90M | 660.10M | 280.73M | 149.47M | 378.45M | |||
All data in EUR